Posted in | News

Boyuan Starts Construction of Commercial Building in China

Boyuan Construction Group, Inc. (TSX-V: BOY & BOY.DB), a fast-growing construction company in China of commercial, residential and municipal infrastructure projects, announced today that it has initiated the building of a commercial project valued at US $23.3 million.

The 35-storey, 115,000 square meter building will be developed in the city of Weifang, in China's Shandong province. The project is expected to be completed by the fourth quarter of 2012. When completed, the building will represent the tallest ever constructed by Boyuan.

"Since expanding into Shandong province last September, we have been very encouraged by the number of opportunities that have emerged where we can apply our commercial and residential construction expertise," said Mr. Cai Liang Shou, Chairman of Boyuan Construction Group. "Our latest contract win is significant in that it shows continued growth in both the value and size of our projects in the region."

As a Class 1 general contractor, Boyuan is licensed to construct buildings up to 40 storeys tall.

Boyuan has signed five major contracts in Shandong since entering the market in September, 2009. With today's contract award, Boyuan's aggregate value of contracts signed thus far in Shandong is US $94 million.

Shandong is one of China's most economically diversified provinces with high concentrations of manufacturing as well as oil and gas production activities. Weifang, one of Shandong's principal cities, has a population of 8.5 million people.

Source: http://www.boyuangroup.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.